![]() |
|
|
Vol. 298, Issue 2, 769-779, August 2001
Department of Neurobiology, Pharmacology, and Physiology,
The University of Chicago, Chicago, Illinois (A.H., N.B., R.L., L.W.);
and Department of Applied Mathematics, Illinois Institute of
Technology, Chicago, Illinois (B.H.)
Methamphetamine use by females of child-bearing age has become a major
public health concern in terms of the long-term risk to the exposed
fetus. We examined the possibility of enhanced adult neurotoxic
potential of the drug in offspring that had been exposed to
methamphetamine in utero during gestational days 7 to 18. While basal
levels of monoamines were not affected by prenatal exposure to
methamphetamine, we observed an enhanced neurotoxicity in adult male
offspring following drug challenge with effects localized primarily to
the dopaminergic nigrostriatal projection. This was evidenced by
greater methamphetamine-induced reductions of dopaminergic markers in
the striatum [dopamine (DA), dihydroxyphenylacetic acid, homovanillic
acid (HVA), and 3-methoxytyramine (3-MT)] and ventral brainstem (DA)
of prenatal methamphetamine-treated males compared with saline-treated
animals. Some effects of prenatal methamphetamine exposure were
observed in female offspring, but these were limited to striatal levels
of 3-MT and HVA. Differential gender sensitivity to the neurotoxic
effect of methamphetamine was shown to be correlated with hyperthermic
response. Hyperthermic effects, however, do not account for the
increased susceptibility of prenatal methamphetamine-treated males to
drug-induced striatal DA neurotoxicity since methamphetamine challenge
did not evoke a significantly greater hyperthermic response in these
animals compared with prenatal saline-treated males. The findings raise the concern that male methamphetamine abusers may be at risk for an
enhanced neurotoxic risk if they were exposed to the drug in utero.